Zeptide Injection 7.5 mg/0.5 ml is a high-efficacy, once-weekly injectable medication formulated with Tirzepatide, a next-generation dual incretin receptor agonist for the treatment of type 2 diabetes mellitus. Tirzepatide uniquely activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, providing comprehensive glycemic control along with favorable effects on body weight and overall metabolic health.

Type 2 diabetes is a progressive metabolic disorder marked by insulin resistance, impaired insulin secretion, and excessive glucagon release. Zeptide Injection addresses these core pathophysiological factors by stimulating glucose-dependent insulin secretion, suppressing inappropriate glucagon secretion, delaying gastric emptying, and reducing appetite. These combined mechanisms result in improved fasting and postprandial blood glucose control and support sustained weight reduction.

The 7.5 mg strength is typically prescribed for patients who have tolerated lower doses and require enhanced glycemic control. With its once-weekly dosing schedule, Zeptide Injection simplifies treatment regimens, improves adherence, and supports long-term diabetes management under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features

Indications

Zeptide Injection 7.5 mg/0.5 ml is indicated for:

• Management of type 2 diabetes mellitus in adult patients

• Improvement of blood glucose control as an adjunct to diet and exercise

• Weight management support in overweight or obese individuals with type 2 diabetes

• Use in combination with other antidiabetic therapies, including metformin or insulin, as prescribed

Active Ingredient

• Tirzepatide 7.5 mg per 0.5 ml

Tirzepatide’s dual GIP and GLP-1 receptor activity provides enhanced metabolic benefits beyond traditional single-incretin therapies.

Benefits

• Dual Incretin Mechanism: Improves insulin sensitivity and secretion while reducing glucagon levels.

• Superior Glycemic Control: Effectively lowers HbA1c, fasting, and postprandial glucose levels.

• Supports Weight Reduction: Helps decrease appetite and caloric intake.

• Once-Weekly Injection: Convenient dosing promotes better patient compliance.

• Glucose-Dependent Action: Reduced risk of hypoglycemia when used appropriately.

Dosage and Administration

• Route: Subcutaneous injection

• Frequency: Once weekly, administered on the same day each week

• Recommended Dose: 7.5 mg once weekly, as directed by a healthcare professional

The injection can be given in the abdomen, thigh, or upper arm. Dose escalation should be gradual and performed under medical supervision. Zeptide Injection is not indicated for type 1 diabetes mellitus or diabetic ketoacidosis.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

Precautions

• Should be used only under the supervision of a qualified healthcare professional.

• Use with caution in patients with a history of pancreatitis or severe gastrointestinal disease.

• Contraindicated in patients with known hypersensitivity to Tirzepatide or any component of the formulation.

• Safety during pregnancy and breastfeeding should be determined by a physician.

Side Effects

• Common side effects include nausea, vomiting, diarrhea, reduced appetite, and abdominal discomfort.

• These effects are generally mild to moderate and often decrease with continued treatment.

Storage

• Store refrigerated at 2°C to 8°C.

• Do not freeze.

• Protect from light.

• Keep out of reach of children.

Why Choose Zeptide Injection?

• Advanced dual-action incretin therapy for improved diabetes outcomes

• Convenient once-weekly dosing for long-term management

• Clinically proven support for both glycemic control and weight reduction

• Trusted formulation quality from SK Pharma.